Avraham Unterman, MD, MBA
Dr. Unterman is a physician-scientist focusing his career on research and clinical practice in idiopathic pulmonary fibrosis and other interstitial lung diseases. After completing his pulmonary fellowship at the Rabin Medical Center in Israel, he joined Dr. Naftali Kaminski’s laboratory as an Instructor at Yale School of Medicine, where he studied the immune system in IPF using the powerful technology of single-cell RNA sequencing (scRNA-seq). During the COVID-19 pandemic he led a large collaborative scRNA-seq study at Yale, uncovering the dyssynchrony of the innate and adaptive immune system in progressive COVID-19.
Dr. Unterman attended medical school at the Technion- Israel Institute of Technology, and completed residency training in internal medicine at the Sheba Medical Center in Israel. He holds a Master of Business Administration (MBA) degree from the Technion and has published over 20 research articles and book chapters. Starting from December 2020, he will be joining the Tel Aviv Sourasky Medical Center in Israel, where he will head the Interstitial Lung Disease Service as well as a research laboratory. His current research focuses on single-cell immune profiling of the peripheral blood to identify the immunological mechanisms that distinguish immune-driven forms of pulmonary fibrosis from IPF, and facilitate the development of precision medicine approaches for diagnosis and treatment.